Nick Paul TaylorCOVID-19NIH-backed project develops scoring system for identifying long-COVID patientsWhile multiple earlier studies have assessed the effects of long COVID, previous efforts largely had retrospective designs, relied on electronic health record entries, and lacked an uninfected comparison group.May 25, 2023COVID-19Medical records link vaccination against COVID-19 to reduced risk of non-respiratory symptomsAn analysis, details of which were presented Tuesday at the ATS 2023 International Conference in Washington, DC, reviewed data from 63,454 patients who were treated in a University of California medical center for COVID-19.May 23, 2023Technology DevelopmentStudy identifies stress hormone in hair as potential biomarker of heart disease riskChronic stress, which is linked to a range of negative health outcomes, is associated with increased levels of glucocorticoids. The body releases the hormone in response to stress.May 22, 2023ConcussionSaliva concussion test in development for female athletes leverages non-coding RNAA panel that tested for 14 non-coding RNAs differentiated concussed subjects from people who were negative on the head injury assessment and a separate control cohort.May 19, 2023Colorectal CancerRunning stool test twice increases colon cancer detection rate in clinical trialThe fecal immunochemical test can deliver false negatives that may delay further investigations and the diagnosis and treatment of colorectal cancer. To try to raise the sensitivity, researchers explored the effects of testing twice.May 18, 2023Inflammatory DiseasePeptide-based diagnostic testing shows promise in the monitoring of inflammatory diseasesSwitching from antibodies to peptides may address testing challenges. Peptides, sequences of up to 50 amino acids, bind to proteins with high affinity and selectivity, making them suitable for use in lateral flow tests.May 17, 2023Non Small Cell Lung CancerBiomarker predicts response to chemo-immunotherapy in lung cancer patientsResearchers see a correlation between CX3CR1 expression and outcomes in NSCLC patients treated with chemo-immunotherapy.May 15, 2023SequencingExperts advocate expanding newborn screening to cover treatable genetic childhood diseasesIncreased knowledge of the genetic drivers for a broader range of diseases and the development of targeted medicines for them means it is now possible to screen and treat a wider range of conditions than is covered by current laboratory screening tests.May 8, 2023Molecular DiagnosticsUC San Francisco becomes first California hospital to offer pharmacogenetic testingWhen a patient agrees to undergo pharmacogenetic testing, UC San Francisco will bill their insurance and post the results in its portal within two weeks.May 4, 2023Bladder CancerBladder cancer biomarker signature could identify likely responders to checkpoint inhibitorsA diagnostic tool that identifies the patients most likely to respond to checkpoint inhibitors could enable physicians to determine the best treatment for each individual.April 27, 2023Page 1 of 5Next PageTop StoriesMalariaMalaria rapid tests in study show low performance for travelers to ChinaThe study evaluated the sensitivity of four parasite enzyme lactate dehydrogenase-targeting RDTs and one aldolase-targeting RDT for P. malariae detection.Regulatory ApprovalFDA grants full approval for antiviral pill to treat mild-to-moderate COVID-19 in adultsDiabetic NephropathyRenalytix selects Eversana to expand commercialization of KidneyIntelX test for diabetic kidney diseaseBusiness InsightsIllumina CEO remains on the board, chairman is voted outSponsor ContentVisit our Molecular Diagnostics Community
